Device Week, 13 April 2022 –Miach And Outset Exec Chats; Medtronic Updates Renal Denervation Trials

In this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology. Listen to the podcast via the player below: The archive of Medtech Insight's Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, and Spotify Podcasts. Medtech Insight articles addressing topics discussed in this episode: Exec Chat: Outset Medical CEO Shares Lessons Learned On Road To Transforming Kidney Care Exec Chat: Miach Orthopedics Bullish On BEAR For Repairing, Not Replacing, Torn ACLs AAOS 2022 Roundup: 3D Printing, Digital Tech In Surgery, Fixation Technologies, Curved Implants AAOS 2022 Roundup: Stryker, Zimmer Biomet, J&J’s DePuy Synthes, Canary Medical Cardiovascular Catch-Up: ACC Brings Encouraging Renal Denervation And TAVR Data For Medtronic Cardiovascular Catch-Up: Philips New AI Finds AF Needle In ECG Haystack; LimFlow Moves Closer To US Approval